Artificial intelligence took three weeks to identify six substances that block an enzyme responsible for fibrosis and other illnesses, according to paper. But ethics expert warns it is ‘a long-term innovation with a complicated learning curve’ and developers and investors ‘should proceed with caution’. — SCMP
Artificial intelligence could help to drastically speed up the discovery of new drugs, and it may have an “immense” impact on China’s biomedical industry, according to a study by a Hong Kong-based pharmaceutical research firm.
Insilico Medicine’s paper, published in the journal Nature Biotechnology on Monday, describes a new AI system that was used to successfully identify six substances that block a certain enzyme responsible for fibrosis and other illnesses. One of the substances was later found to be effective in treating mice with renal fibrosis.
Limited time offer:
Just RM5 per month.
